Multi-parameter optimization: Development of a morpholin-3-one derivative with an improved kinetic profile for imaging monoacylglycerol lipase in the brain-Reference-Cited by-同舟云学术

Multi-parameter optimization: Development of a morpholin-3-one derivative with an improved kinetic profile for imaging monoacylglycerol lipase in the brain

Published:2022-12 Issue: Volume:243 Page:114750
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

He Yingfang,Grether Uwe,Taddio Marco F.,Meier Carla,Keller Claudia,Edelmann Martin R.,Honer Michael,Huber Sylwia,Wittwer Matthias B.,Heer Dominik,Richter Hans,Collin Ludovic,Hug Melanie N.,Hilbert Manuel,Postmus Annemarieke G.J.,Stevens Anna Floor,van der Stelt Mario,Krämer Stefanie D.,Schibli Roger,Mu Linjing,Gobbi Luca C.

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference24 articles.

1. Targeting the endocannabinoid system: future therapeutic strategies;Aizpurua-Olaizola;Drug Discov. Today,2017

2. Endocannabinoid-mediated retrograde modulation of synaptic transmission;Ohno-Shosaku;Curr. Opin. Neurobiol.,2014

3. A dysregulated endocannabinoid-eicosanoid network supports pathogenesis in a mouse model of Alzheimer's disease;Piro;Cell Rep.,2012

4. Monoacylglycerol lipase (MAGL) as a promising therapeutic target;Gil-Ordóñez;Biochem. Pharmacol.,2018

5. Targeting endocannabinoid signaling: FAAH and MAG lipase inhibitors;van Egmond;Annu. Rev. Pharmacol. Toxicol.,2021

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Endocannabinoid Hydrolase Inhibitors: Potential Novel Anxiolytic Drugs;Drug Design, Development and Therapy;2024-06

2. Preclinical Evaluation of the Reversible Monoacylglycerol Lipase PET Tracer (R)‐[¹¹C]YH132: Application in Drug Development and Neurodegenerative Diseases;ChemBioChem;2024-03-05

3. Exploring the structural-activity relationship of hexahydropyrazino[1,2-d]pyrido[3,2-b][1,4]oxazine derivatives as potent and orally-bioavailable PARP7 inhibitors;European Journal of Medicinal Chemistry;2023-12

4. Strategies for designing novel positron emission tomography (PET) radiotracers to cross the blood–brain barrier;Journal of Labelled Compounds and Radiopharmaceuticals;2023-04-14